Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study

Bibliographic Details
Main Authors:	Yamaguchi, Kensei, Sawaki, Akira, Doi, Toshihiko, Satoh, Taroh, Yamada, Yasuhide, Omuro, Yasushi, Nishina, Tomohiro, Boku, Narikazu, Chin, Keisho, Hamamoto, Yasuo, Takiuchi, Hiroya, Komatsu, Yoshito, Saji, Shigehira, Koizumi, Wasaburo, Miyata, Yoshinori, Sato, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Ohtsu, Atsushi
Format:	Online
Language:	English
Published:	Springer Japan 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079605/

Similar Items

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
by: Yamaguchi, Kensei, et al.
Published: (2012)

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
by: Sawaki, Akira, et al.
Published: (2011)

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
by: Doi, Toshihiko, et al.
Published: (2015)

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
by: Yoshino, Takayuki, et al.
Published: (2012)

Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
by: Saji, Shigehira
Published: (2013)

Erratum to: Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
by: Saji, Shigehira
Published: (2013)

HER2-positive gastric cancer
by: Boku, Narikazu
Published: (2013)

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
by: Doi, Toshihiko, et al.
Published: (2014)

Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial
by: Hacker, Ulrich T, et al.
Published: (2016)

Impact of body mass index on breast cancer in accordance with the life-stage of women
by: Suzuki, Reiko, et al.
Published: (2012)

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial
by: Shiroiwa, T, et al.
Published: (2011)

Struktur Togas Persaingan dan Kerjasama dalam Proses Kumpulan dan lmplikasi Terhadap Amalan Pendidikan
by: Othman, Ghazali
Published: (1986)

Genes for the Major Structural Components of Thermotogales Species’ Togas Revealed by Proteomic and Evolutionary Analyses of OmpA and OmpB Homologs
by: Petrus, Amanda K., et al.
Published: (2012)

PLASTIC WASTE CONVERSION METHOD OF PLASTIC BOTTLE THROUGH TOGA CULTIVATION WITH ECO-FRIENDLY VERTICULTURAL SYSTEM
by: Agung Kurniawan
Published: (2017-12-01)

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
by: Van Cutsem, Eric, et al.
Published: (2014)

Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial
by: Han, Kelong, et al.
Published: (2014)

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors
by: Murakami, Haruyasu, et al.
Published: (2012)

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†
by: Boku, Narikazu, et al.
Published: (2014)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
by: Tahara, Makoto, et al.
Published: (2015)

Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study
by: Yoshino, Takayuki, et al.
Published: (2015)

Capecitabine in the management of colorectal cancer
by: Hirsch, Bradford R, et al.
Published: (2011)

Capecitabine-Induced Coronary Vasospasm
by: Henry, Danish, et al.
Published: (2016)

Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method
by: Chao, Wan-Ru, et al.
Published: (2015)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
by: Suenaga, Mitsukuni, et al.
Published: (2015)

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study
by: Nagasaka, Takeshi, et al.
Published: (2016)

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit
by: Bando, Hideaki, et al.
Published: (2013)

Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)

Severe hypertriglyceridaemia during treatment with capecitabine
by: Javot, L, et al.
Published: (2011)

Ileitis Secondary to Oral Capecitabine Treatment?
by: Radwan, Rami, et al.
Published: (2012)

A Case of Capecitabine-Induced Sarcoidosis
by: Kang, Shin Myung, et al.
Published: (2012)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
by: Oblak, Irena, et al.
Published: (2014)

Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial
by: Zhou, Fei, et al.
Published: (2012)

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
by: Wist, E. A., et al.
Published: (2012)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
by: Lee, Sung Uk, et al.
Published: (2013)

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
by: LIANG, XU, et al.
Published: (2015)

Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial
by: Ioka, Tatsuya, et al.
Published: (2015)

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
by: Yoshino, Takayuki, et al.
Published: (2014)

Response of Cutaneous Metastases from Breast Cancer to Capecitabine
by: Sideras, Kostandinos, et al.
Published: (2008)

Hypokalemia secondary to capecitabine: a hidden toxicity?
by: Saif, Muhammad Wasif, et al.
Published: (2007)

Use of capecitabine in management of early colon cancer
by: Hameed, H, et al.
Published: (2011)